Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2001

View Archived Issues

Primary endpoint achieved in phase III trial of Gilead's adefovir dipivoxil for HBV

Use of PRAC protein in cancer Rx available for licensing from NIH

Licensing opportunity from NIH: new small RNAs as starting point for antibiotic development

Medicure presents drug with potential for healing ischemic injury

Protein Therapeutics begins phase II trial in juvenile RA

Medivir highlights pipeline progress for first half of 2001

Design of mixed direct thrombin and factor Xa inhibitors reported at ISTH

Antiplatelet antibody fragment designed at Chinese university

HTU-PA is a safe and effective thrombolytic agent in acute myocardial infarction

Beneficial effects of humanized anti-hTF antibody in hypercoagulable states

Safer anticoagulation obtained with Ro-67-8698, a new factor VIIa inhibitor, than napsagatran

MabCampath approved in Europe for B-CLL

Lilly Icos seeks European approval of Cialis for treatment of erectile dysfunction

Sea cucumber-based therapy useful for age-associated dementia

EMEA accepts Oxford GlycoSciences' MAA for Vevesca

Cangene halts pilot phase II trial of anti-HCV hyperimmune product

Protective effect demonstrated for FR-167653 against aspirin-induced gastric damage

FTY-720: effects on lymphocytes and in animal models of autoimmune diseases

Ramoplanin granted orphan drug status in Europe

EntreMed begins enrollment of initial patients in phase I/II study of rhEndostatin

Antithrombotic pentasaccharide covered extensively at recent scientific meeting

Inhibitors of PDE4 and use in asthma, allergies, etc.

Merck & Co. presents new pyrazinone thrombin inhibitors

Agents for HBV and HIV described in patent literature by Korean lab

Tie2 receptor kinase inhibitors useful for angiogenic disorders

Urotensin II analogues and pharmaceutical compositions for stroke and other disorders

Venlafaxine metabolite ethers with same pharmacological profile as venlafaxine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...